AnGes, Inc. (4563.T)

JPY 65.0

(1.56%)

Long Term Debt Summary of AnGes, Inc.

  • AnGes, Inc.'s latest annual long term debt in 2023 was 214.94 Million JPY , down -78.4% from previous year.
  • AnGes, Inc.'s latest quarterly long term debt in 2024 Q2 was 173.63 Million JPY , down 0.0% from previous quarter.
  • AnGes, Inc. reported annual long term debt of 994.96 Million JPY in 2022, down 0.0% from previous year.
  • AnGes, Inc. reported annual long term debt of - JPY in 2021, down 0.0% from previous year.
  • AnGes, Inc. reported quarterly long term debt of 196.84 Million JPY for 2024 Q1, down 0.0% from previous quarter.
  • AnGes, Inc. reported quarterly long term debt of 965.24 Million JPY for 2023 Q1, down -2.99% from previous quarter.

Annual Long Term Debt Chart of AnGes, Inc. (2023 - 2008)

Historical Annual Long Term Debt of AnGes, Inc. (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 214.94 Million JPY -78.4%
2022 994.96 Million JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%
2018 - JPY 0.0%
2017 - JPY 0.0%
2016 - JPY 0.0%
2015 - JPY 0.0%
2014 - JPY 0.0%
2013 - JPY 0.0%
2012 - JPY 0.0%
2011 - JPY 0.0%
2010 - JPY 0.0%
2009 - JPY 0.0%
2008 - JPY 0.0%

Peer Long Term Debt Comparison of AnGes, Inc.

Name Long Term Debt Long Term Debt Difference
KOHJIN BIO CO LTD 767.03 Million JPY 71.977%
PRISM BioLab Co.,LTD - JPY -Infinity%
GNI Group Ltd. 2 Billion JPY 89.253%
Linical Co., Ltd. 1.49 Billion JPY 85.67%
Trans Genic Inc. 1.32 Billion JPY 83.803%
MEDINET Co., Ltd. 781 Thousand JPY -27422.279%
Soiken Holdings Inc. - JPY -Infinity%
Cytori Cell Research Institute, Inc. 2.34 Billion JPY 90.842%
OncoTherapy Science, Inc. 106.84 Million JPY -101.171%
Nxera Pharma Co., Ltd. 63.21 Billion JPY 99.66%
Immuno-Biological Laboratories Co., Ltd. 84.56 Million JPY -154.194%
NanoCarrier Co., Ltd. 1.1 Billion JPY 80.616%
Carna Biosciences, Inc. 28.4 Million JPY -656.809%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 875.59 Million JPY 75.451%
RaQualia Pharma Inc. 39.05 Million JPY -450.446%
Chiome Bioscience Inc. - JPY -Infinity%
Kidswell Bio Corporation 1.83 Billion JPY 88.305%
PeptiDream Inc. 19.63 Billion JPY 98.905%
Oncolys BioPharma Inc. 161.1 Million JPY -33.426%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited 397 Million JPY 45.857%
Healios K.K. 450 Million JPY 52.234%
BrightPath Biotherapeutics Co., Ltd. - JPY -Infinity%
Kubota Pharmaceutical Holdings Co., Ltd. - JPY -Infinity%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 77.29 Million JPY -178.104%
FunPep Company Limited - JPY -Infinity%
Kringle Pharma, Inc. - JPY -Infinity%
Stella Pharma Corporation 773.29 Million JPY 72.203%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. - JPY -Infinity%
Cuorips Inc. - JPY -Infinity%
K Pharma,Inc. - JPY -Infinity%
Takara Bio Inc. 788 Million JPY 72.722%
ReproCELL Incorporated - JPY -Infinity%
PhoenixBio Co., Ltd. 491.35 Million JPY 56.253%
StemCell Institute Inc. 6.67 Million JPY -3119.727%
Japan Tissue Engineering Co., Ltd. - JPY -Infinity%
CellSeed Inc. 143.75 Million JPY -49.53%